Skip to main content
. 2024 Mar 7;2024:3028617. doi: 10.1155/2024/3028617

Table 6.

Types of LTP treatment used in HAE type I/II compared to HAE nC1-INH.

HAE type I/II (n = 17), n (%) HAE nC1-INH (n = 15), n (%)
Treatment(s) you have received as LTP
Tranexamic acid 3 (18%) 9 (60%)
SC C1-INH concentrate 9 (53%) 3 (20%)
IV C1-INH concentrate 7 (41%) 3 (20%)
Other 3 (18%) 0 (0%)

C1-INH, C1 inhibitor; HAE, hereditary angioedema; HAE nC1-INH, hereditary angioedema with normal C1 inhibitor; IV, intravenous; LTP, long-term prophylaxis; SC, subcutaneous.